Revvity, Inc. (RVTY)
NYSE · Common stock · Laboratory Analytical Instruments
As of Oct 21, 11:10 AM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow RVTY in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on RVTY and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
RVTY at a glance
Key statistics
$17.41B
Market capitalization
- Previous close
- $156.01
- Open
- $156.00
- Day range
- $153.49 – $158.86
- Volume
- 426.1K
- Average volume (30 sessions)
- 2.08M
- Shares outstanding
- 111.59M
- Price / earnings
- 73.3
- Earnings per share
- $2.13
- Price / book
- 2.4
- Price / sales
- 6.0
- Dividend yield
- 0.18%
- Beta (1 year, vs SPY)
- 1.16
Where the price sits in its year
52-week range
90% of the range
- Below the 52-week high
- -4.9%
- Above the 52-week low
- +94.6%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $152.44+2.3%
- 50-day average
- $137.65+13.3%
- 200-day average
- $109.68+42.2%
Between the conventional 30 and 70 bands.
+0.6%
1 week
+8.6%
1 month
+41.1%
3 months
+61.3%
Year to date
+67.0%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with RVTY
RVTY on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on RVTY.
See the plans →
Every planScreen names like RVTY
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on RVTY
Put RVTY on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on RVTY
See whether there is an open premium alert on RVTY, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
RVTY headlines
- Revvity Slashes Outlook As China Policy Deals Diagnostics Blow
Benzinga · Jul 28, 2025
- CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs
GlobeNewswire Inc. · Oct 21, 2024
- 4 Analysts Have This To Say About Revvity
Benzinga · Apr 30, 2024
- The Latest Analyst Ratings For Revvity
Benzinga · Jan 25, 2024
- Peeling Back The Layers: Exploring Revvity Through Analyst Insights
Benzinga · Jan 4, 2024
- 7 Analysts Have This to Say About Revvity
Benzinga · Dec 13, 2023
SEC Form 4, most recent first
Insider filings
Gonzales Anita
−84
VP and CAO · Open-market sale
$13.06K · Oct 1, 2026
Krakowiak Maxwell
−1.6K
Please See Remarks · Open-market sale
$235.73K · Sep 21, 2026
Vohra Tajinder S
−7.3K
Please See Remarks · Open-market sale
$1.03M · Sep 16, 2026
MICHAS ALEXIS P
−285
Director · Gift
· Aug 25, 2026
Goldberg Joel S
−27.8K
Please See Remarks · Gift
· Aug 14, 2026
Goldberg Joel S
+27.8K
Please See Remarks · Gift
· Aug 14, 2026
Singh Prahlad R.
+7.6K
Please See Remarks, Director · Gift
· Aug 13, 2026
Singh Prahlad R.
−59.6K
Please See Remarks, Director · Gift
· Aug 13, 2026
About Revvity, Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Waltham, MA
- Employees
- 11,000
- Listed since
- Jun 1, 1972
- Website
- revvity.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.